[Federal Register Volume 77, Number 120 (Thursday, June 21, 2012)]
[Notices]
[Page 37446]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-15173]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of Meeting.
-----------------------------------------------------------------------
SUMMARY: NRC will convene a teleconference meeting of the Advisory
Committee on the Medical Uses of Isotopes (ACMUI) on July 9, 2012. The
purpose of the meeting will be to discuss the radium-223 chloride
subcommittee report. NRC will also convene a regular meeting of the
ACMUI on September 20-21, 2012. A sample of agenda items to be
discussed during the public session includes: (1) Reducing occupational
dose limits; (2) status of data collection on patient release; (3)
status update on 10 CFR part 35 rulemaking; (4) status update on
proposed regulatory changes for permanent implant brachytherapy
programs; (5) follow-up on ACMUI reporting structure; and (6) update on
domestic production of molybdenum-99. The regular meeting agenda is
subject to change. The current agendas for both meetings and any
updates will be available prior to the meetings at http://www.nrc.gov/reading-rm/doc-collections/acmui/agenda or by emailing Ms. Ashley
Cockerham at the contact information below.
Purpose: Discuss issues related to 10 CFR Part 35 Medical Use of
Byproduct Material.
Date and Time for Teleconference Meeting: July 9, 2012, from 11:00
a.m. to 12:00 p.m.
Date and Time for Regular Meeting Closed Session: September 20,
2012, from 8:30 a.m. to 11:30 a.m. This session will be closed for
ACMUI training.
Date and Time for Regular Meeting Open Sessions: September 20,
2012, from 1:00 p.m. to 5:00 p.m. and September 21, 2012, from 8:30
a.m. to 12:00 p.m. Regular meeting times are subject to change.
Address for Regular Meeting: U.S. Nuclear Regulatory Commission,
Two White Flint North Building, Room T2-B3, 11545 Rockville Pike,
Rockville, Maryland 20852.
Public Participation: Any member of the public who wishes to
participate in the meetings in person or via phone should contact Ms.
Cockerham using the information below. The regular meeting on September
20-21 will also be webcast live at http://video.nrc.gov.
Contact Information: Ashley Cockerham, email:
[email protected], telephone: (240) 888-7129.
Conduct of the Meeting
Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will
conduct the meeting in a manner that will facilitate the orderly
conduct of business. The following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Cockerham at the contact information listed
above. All submittals must be received five business days prior to the
meeting and must pertain to the topic on the agenda for the meeting.
2. Questions and comments from members of the public will be
permitted during the meeting at the discretion of the Chairman.
3. The draft transcripts will be available on ACMUI's Web site
(http://www.nrc.gov/reading-rm/doc-collections/acmui/tr/) within 30
business days of the meeting. A meeting summary will be available on
ACMUI's Web site (http://www.nrc.gov/reading-rm/doc-collections/acmui/meeting-summaries/) within 30 business days of the meeting.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. Cockerham of their planned
attendance.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in Title
10, U.S. Code of Federal Regulations, Part 7.
Dated: June 14, 2012.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2012-15173 Filed 6-20-12; 8:45 am]
BILLING CODE 7590-01-P